ID23521A - Turunan-turunan karbostiril - Google Patents
Turunan-turunan karbostirilInfo
- Publication number
- ID23521A ID23521A IDW20000312A ID20000312A ID23521A ID 23521 A ID23521 A ID 23521A ID W20000312 A IDW20000312 A ID W20000312A ID 20000312 A ID20000312 A ID 20000312A ID 23521 A ID23521 A ID 23521A
- Authority
- ID
- Indonesia
- Prior art keywords
- pct
- lower alkyl
- date feb
- sec
- hydrogen atom
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 abstract 2
- 206010015150 Erythema Diseases 0.000 abstract 1
- 208000012641 Pigmentation disease Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22243197 | 1997-08-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID23521A true ID23521A (id) | 2000-04-27 |
Family
ID=16782296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20000312A ID23521A (id) | 1997-08-19 | 1998-08-18 | Turunan-turunan karbostiril |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6133264A (id) |
| EP (1) | EP1005458B1 (id) |
| JP (1) | JPH11124366A (id) |
| KR (1) | KR100397201B1 (id) |
| CN (1) | CN1141298C (id) |
| AR (1) | AR013945A1 (id) |
| AT (1) | ATE279395T1 (id) |
| AU (1) | AU725464B2 (id) |
| BR (1) | BR9811307A (id) |
| CA (1) | CA2297439C (id) |
| DE (1) | DE69827014T2 (id) |
| DK (1) | DK1005458T3 (id) |
| EG (1) | EG24161A (id) |
| ES (1) | ES2232001T3 (id) |
| ID (1) | ID23521A (id) |
| MY (1) | MY115907A (id) |
| PT (1) | PT1005458E (id) |
| TW (1) | TW436483B (id) |
| WO (1) | WO1999009011A1 (id) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020034772A1 (en) | 1999-06-29 | 2002-03-21 | Orlow Seth J. | Methods and compositions that affect melanogenesis |
| US20020114769A1 (en) * | 2000-09-14 | 2002-08-22 | Rotenberg Susan A. | Novel dequalinium analogs |
| WO2011094016A1 (en) | 2010-01-28 | 2011-08-04 | New York University | Compounds, compositions and methods for preventing skin darkening |
| WO2012103487A1 (en) | 2011-01-27 | 2012-08-02 | New York University | Coumarin compounds as melanogenesis modifiers and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1219587A (en) * | 1981-12-14 | 1987-03-24 | Norman P. Jensen | Hydroxybenzylaminobenzenes as anti-inflammatory agents |
| US5082847A (en) * | 1990-07-18 | 1992-01-21 | Syntex (U.S.A.) Inc. | Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility |
| US5576324A (en) * | 1992-05-01 | 1996-11-19 | Kowa Co., Ltd. | Quinoline derivatives or salt thereof and remedy for cardiac diseases containing the same |
| TW448161B (en) * | 1994-07-14 | 2001-08-01 | Otsuka Pharma Co Ltd | Cyclic amide derivatives |
| JP3042894B2 (ja) * | 1995-07-07 | 2000-05-22 | ファイザー製薬株式会社 | サブスタンスpアンタゴニストとしての置換ベンゾラクタム化合物 |
| EP0918522A4 (en) * | 1996-05-20 | 1999-08-18 | Merck & Co Inc | GONADOLIBERIN ANTAGONISTS |
| WO1997044321A1 (en) * | 1996-05-20 | 1997-11-27 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
-
1998
- 1998-07-23 TW TW087112066A patent/TW436483B/zh not_active IP Right Cessation
- 1998-08-13 EG EG94298A patent/EG24161A/xx active
- 1998-08-17 JP JP10230407A patent/JPH11124366A/ja active Pending
- 1998-08-18 US US09/485,454 patent/US6133264A/en not_active Expired - Fee Related
- 1998-08-18 DK DK98937851T patent/DK1005458T3/da active
- 1998-08-18 DE DE69827014T patent/DE69827014T2/de not_active Expired - Fee Related
- 1998-08-18 CN CNB988082772A patent/CN1141298C/zh not_active Expired - Fee Related
- 1998-08-18 MY MYPI98003752A patent/MY115907A/en unknown
- 1998-08-18 AT AT98937851T patent/ATE279395T1/de not_active IP Right Cessation
- 1998-08-18 EP EP98937851A patent/EP1005458B1/en not_active Expired - Lifetime
- 1998-08-18 ID IDW20000312A patent/ID23521A/id unknown
- 1998-08-18 ES ES98937851T patent/ES2232001T3/es not_active Expired - Lifetime
- 1998-08-18 CA CA002297439A patent/CA2297439C/en not_active Expired - Fee Related
- 1998-08-18 WO PCT/JP1998/003657 patent/WO1999009011A1/en not_active Ceased
- 1998-08-18 KR KR10-2000-7001705A patent/KR100397201B1/ko not_active Expired - Fee Related
- 1998-08-18 PT PT98937851T patent/PT1005458E/pt unknown
- 1998-08-18 BR BR9811307-0A patent/BR9811307A/pt not_active IP Right Cessation
- 1998-08-18 AU AU86500/98A patent/AU725464B2/en not_active Ceased
- 1998-08-18 AR ARP980104065A patent/AR013945A1/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010023086A (ko) | 2001-03-26 |
| CA2297439C (en) | 2006-12-19 |
| CA2297439A1 (en) | 1999-02-25 |
| CN1141298C (zh) | 2004-03-10 |
| AU725464B2 (en) | 2000-10-12 |
| BR9811307A (pt) | 2000-08-29 |
| TW436483B (en) | 2001-05-28 |
| AR013945A1 (es) | 2001-01-31 |
| JPH11124366A (ja) | 1999-05-11 |
| US6133264A (en) | 2000-10-17 |
| DK1005458T3 (da) | 2005-01-31 |
| MY115907A (en) | 2003-09-30 |
| DE69827014T2 (de) | 2005-03-17 |
| KR100397201B1 (ko) | 2003-09-13 |
| ATE279395T1 (de) | 2004-10-15 |
| PT1005458E (pt) | 2005-01-31 |
| EG24161A (en) | 2008-08-20 |
| HK1029346A1 (en) | 2001-03-30 |
| EP1005458A1 (en) | 2000-06-07 |
| AU8650098A (en) | 1999-03-08 |
| ES2232001T3 (es) | 2005-05-16 |
| EP1005458B1 (en) | 2004-10-13 |
| DE69827014D1 (de) | 2004-11-18 |
| WO1999009011A1 (en) | 1999-02-25 |
| CN1267284A (zh) | 2000-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200420542A (en) | A compound having TGF β inhibition activity and a medicinal composition containing the same | |
| EP1130017A3 (en) | Azole derivatives and their use as superoxide radical inhibitors | |
| YU19002A (sh) | Derivati hinolil-propil-piperidina, njihovo dobivanje i smeše koje ih sadrže | |
| NO20024424L (no) | Glykopyranosyloksybenzylbenzenderivater, medisinske sammensetninger inneholdende slike, samt intermediater tilfremstilling av derivatene | |
| EP0945452A4 (en) | SUGAR COMPOSITIONS, GELLING AGENTS, GELLING AGENT COMPOSITIONS, METHODS OF PREPARING SAME, AND GEL COMPOSITIONS | |
| ATE235476T1 (de) | Thiazolidindione derivate, ihre herstellung und verwendung | |
| ATE159722T1 (de) | Dihalotriazolopyrimidinderivate als fugizide | |
| DK0696281T3 (da) | Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater | |
| MA27573A1 (fr) | Sinomenine et derives de sinomenine, synthese et utilisation. | |
| NO20004485D0 (no) | Sykloalkenderivater, deres fremstilling og anvendelse | |
| KR920008024A (ko) | 퀴놀린 유도체 | |
| CA2242242A1 (en) | Quinolonecarboxylic acid derivatives or salts thereof | |
| SE8006498L (sv) | Karbostyrilderivat samt forfarande for framstellning av dem | |
| DE69801594D1 (de) | Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung | |
| CA2192555A1 (en) | 2-acylaminopropanol compound and medicinal composition | |
| KR960022486A (ko) | 신규 티아졸리딘-4-온 유도체 | |
| ATE513821T1 (de) | Thiadiazolin-derivate zur behandlung von krebs | |
| PT1005458E (pt) | Derivados de carboestirilo para inibicao do eritema cutaneo e/ou da pigmentacao cutanea | |
| ATE321552T1 (de) | 1-substituierte-phenyl-1-(1h-imidazol-4- yl)alkohole, verfahren zu deren herstellung sowie deren verwendung | |
| BR9709393A (pt) | Derivados de n-bis ou n-tris-[(1,2-dicarbóxietóxi)etil] amina e preparação e uso dos mesmos | |
| NO951072L (no) | Polyjoderte forbindelser, fremgangsmåte for deres fremstilling og diagnostisk preparat | |
| FR2726271B1 (fr) | Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole | |
| CA2230516A1 (en) | Pyrimidine derivatives | |
| EP1092763A3 (en) | Antimicrobial detergent composition | |
| GEP20074256B (en) | Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing |